Endo (NDOI) stock gains as the company is in pact with Mallinckrodt (MNKTQ) to merge in a $6.7B deal, creating a Dublin-based pharma leader. Read more here.
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
The 500 largest family businesses generate US$8.8t and employ more than 25 million people across 43 jurisdictionsNearly half participated in M&A activities in the last two yearsMore than a third ...
The last several years saw a relative dearth of mergers and acquisitions amid higher interest rates and a skeptical ...
Nishen Radia is managing partner and co-founder of FocalPoint Partners, a leading investment bank headquartered in Los ...
Cohen has experience in various media and entertainment transactions, including financing the development and production of ...
The global Gamma Linolenic Acid (GLA) market is anticipated to reach a valuation of USD 197.2 million by 2025. With an estimated compound annual growth rate (CAGR) of 4.9%, the market is expected to ...
Barrick Gold must pay British dealmaker Ian Hannam's firm $2-million plus expenses for his work on the acquisition of gold ...
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of its client, Hof ...
The investment bank and deal tracker is forecasting another record year as firms look to diversify services and private ...
Law firms can grow by mergers and acquisitions, but there’s another, little-noted way to build the business: by adding new ...
Jerilee Beaudoin thought she’d found the last chapter of her career when in 2020 she joined The Arc of Rensselaer County, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback